Cubist Systematic Strategies’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Cubist Systematic Strategies’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-169,781	Closed	-$1.21M	–	2607
2020 Q1	$1.21M	Buy	169,781 +131,371	+342%	+$1.64M	0.03%	715
2019 Q4	$917K	Buy	38,410 +30,290	+373%	+$836K	0.02%	1218
2019 Q3	$218K	Sell	8,120 -49,253	-86%	-$1.38M	﹤0.01%	1735
2019 Q2	$1.56M	Buy	+57,373	New	+$1.8M	0.03%	805
2018 Q4	–	Sell	-11,903	Closed	-$317K	–	2384
2018 Q3	$317K	Sell	11,903 -903	-7%	-$29.5K	0.02%	1126
2018 Q2	$484K	Buy	+12,806	New	+$490K	0.02%	801
2017 Q4	–	Sell	-4,039	Closed	-$218K	–	2191
2017 Q3	$218K	Buy	+4,039	New	+$237K	0.01%	1391
2016 Q2	–	Sell	-46,878	Closed	-$956K	–	1965
2016 Q1	$956K	Buy	46,878 +31,105	+197%	+$987K	0.05%	485
2015 Q4	$812K	Buy	+15,773	New	+$765K	0.05%	576
2015 Q3	–	Sell	-7,813	Closed	-$356K	–	2094
2015 Q2	$356K	Sell	7,813 -5,210	-40%	-$210K	0.02%	1131
2015 Q1	$494K	Buy	+13,023	New	+$447K	0.02%	943

Other funds holding PTLA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Cubist Systematic Strategies's PTLA Position: Q2 2020 in Review

Cubist Systematic Strategies sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 169,781 shares — an estimated $1.21M sold.

Cubist Systematic Strategies first reported a position in PTLA in Q1 2015 and held it in 11 quarters. The position peaked at $1.56M in Q2 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

Cubist Systematic Strategies reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Cubist Systematic Strategies sold 169,781 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $1.21M.
Cubist Systematic Strategies first reported a position in Portola Pharmaceuticals, Inc. in Q1 2015 and held it in 11 quarters.
Cubist Systematic Strategies's Portola Pharmaceuticals, Inc. position peaked at $1.56M in Q2 2019.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Cubist Systematic Strategies's 13F filing for Q2 2020, filed 14 Aug 2020.